ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

Preliminary Report Tends To Support Pill’s Association With Liver Tumors

November 19, 1976

Workshop Calls For Improved Surgical Oncology Training Programs

December 2, 1983

EU Gives Marketing Approval For HBV Sequencing Test

April 29, 2011

Gallo Group Finds Another Human Virus

November 7, 1986

Number of Cancer Deaths Rise Slightly Due To Population Growth And Aging.

February 22, 2008

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004